Speaker:
Evan Liddington, PharmD, MBA, PGY2 Oncology Resident, Geisinger - has nothing to disclose.
Moderator:
Tristan Maiers, PharmD, BCOP, PGY2 Residency Program Director, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to: -
- Review updates from Heme/Onc P&T and Beacon subcommittees
- Explain the definition of a non-formulary drug
- Describe the process for non-formulary requests
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Tristan Maiers, PharmD, BCOP, Rajiv Panikkar, MD, Michele Long, BSN, Jaime Weeder, NP, Christopher Kashi, PA, and Celeste Vanhorn, CphT have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
Session date:
12/16/2025 - 7:00am to 8:00am EST
Location:
Virtual via Microsoft Teams
Danville, PA
17822
United States
See map: Google Maps
Add to calendar:
- 1.00 AAPA Category I CME
- 1.00 ACPE
- 1.00 ACPE Tech
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation Credit

Facebook
X
LinkedIn
Forward